Choosing a class IC antiarrhythmic drug for the treatment of patients without structural heart disease: clinical advantages of the most common agents (literature review)
Aim: to analyze the pharmacological features and updated evidence-based medicine data of Class IC antiarrhythmic drug (AAD) ethacizine compared to propafenone to optimize the choice of treatment for cardiac arrhythmias in patients without structural heart disease. Materials and methods. According...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Zaporizhzhia State Medical and Pharmaceutical University
2025-09-01
|
| Col·lecció: | Сучасні медичні технології |
| Matèries: | |
| Accés en línia: | https://medtech.mphu.edu.ua/article/view/336359/328345 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|